These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Prednisone treatment of chronic liver disease. I. Chronic aggressive hepatitis as a therapeutic marker. Schlichting P; Fauerholdt L; Christensen E; Poulsen H; Juhl E; Tygstrup N Liver; 1982 Jun; 2(2):104-12. PubMed ID: 7176839 [TBL] [Abstract][Full Text] [Related]
5. Effect of prednisone on the survival of patients with cirrhosis of the liver. A report from the Copenhagen Study Group for Liver Diseases. Lancet; 1969 Jan; 1(7586):119-21. PubMed ID: 4178242 [No Abstract] [Full Text] [Related]
6. Sex, ascites and alcoholism in survival of patients with cirrhosis. Effect of prednisone. Copenhagen Study Group for Liver Diseases N Engl J Med; 1974 Aug; 291(6):271-3. PubMed ID: 4600899 [No Abstract] [Full Text] [Related]
7. Changes of laboratory variables with time in cirrhosis: prognostic and therapeutic significance. Christensen E; Schlichting P; Fauerholdt L; Juhl E; Poulsen H; Tygstrup N Hepatology; 1985; 5(5):843-53. PubMed ID: 2411649 [TBL] [Abstract][Full Text] [Related]
8. Prednisone and chronic liver disease. II. Clinical versus morphological criteria for selection of patients for prednisone treatment. Schlichting P; Christensen E; Fauerholdt L; Poulsen H; Juhl E; Tygstrup N Liver; 1982 Jun; 2(2):113-8. PubMed ID: 7176840 [TBL] [Abstract][Full Text] [Related]
9. Alcoholic hepatitis superimposed on cirrhosis. Clinical significance and effect of long-term prednisone treatment. Schlichting P; Juhl E; Poulsen H; Winkel P Scand J Gastroenterol; 1976; 11(3):305-12. PubMed ID: 775615 [TBL] [Abstract][Full Text] [Related]
11. The effect of prednisone on serum cholesterol in patients with cirrhosis of the liver. Boberg F; Hattel T; Nielsen OE Scand J Gastroenterol; 1972; 7(8):723-6. PubMed ID: 4565595 [No Abstract] [Full Text] [Related]
12. Individual therapy-dependent prognosis based on data from controlled clinical trials in chronic liver disease. Christensen E Dan Med Bull; 1988 Apr; 35(2):167-82. PubMed ID: 3282812 [TBL] [Abstract][Full Text] [Related]
14. Main causes of death in cirrhosis. Schlichting P; Christensen E; Fauerholdt L; Poulsen H; Juhl E; Tygstrup N Scand J Gastroenterol; 1983 Oct; 18(7):881-8. PubMed ID: 6374868 [TBL] [Abstract][Full Text] [Related]
15. The causes of death in prednisone treated and control patients with cirrhosis. Sloth K; Juhl E; Tygstrup N Scand J Gastroenterol Suppl; 1970; 7():189-93. PubMed ID: 5271843 [No Abstract] [Full Text] [Related]
16. A biomedical computer programme system for controlled trials. Juhl E; Winkel P; Frank H; Tygstrup N Scand J Gastroenterol Suppl; 1970; 7():195-201. PubMed ID: 4917039 [No Abstract] [Full Text] [Related]
17. Effect of selection in controlled clinical trials. A supplement to the CSL prednisone trial in cirrhosis. Juhl E; Hilden M; Tygstrup N Scand J Gastroenterol Suppl; 1971; 9():171-5. PubMed ID: 5284140 [No Abstract] [Full Text] [Related]
18. An analysis of prognostic factors in cirrhosis. Wang JY; Liu HY; Zhu WN; Han JQ; Dong CY; Shi YJ; Cai HJ; Cao JM; Yi QL Chin Med J (Engl); 1989 Apr; 102(4):266-72. PubMed ID: 2507240 [TBL] [Abstract][Full Text] [Related]
19. [Current problems in clinical aspects and therapy of liver cirrhosis]. Pfleiderer T Wien Med Wochenschr; 1970 Sep; 120(38):635-40. PubMed ID: 5518114 [No Abstract] [Full Text] [Related]